NGNE - Neurogene Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.00
DETAILS
HIGH:
$69.00
LOW:
$69.00
MEDIAN:
$69.00
CONSENSUS:
$69.00
UPSIDE:
149.01%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 16.56 |
| Quick Ratio | 16.56 |
| Solvency Ratio | -3.810 |
| Cash Ratio | 6.33 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-4.83
Peers avg: 19.1
|
| PEG Ratio | 5.16 |
| Forward PEG | 5.16 |
| Price/Book | 1.65 |
| Price/Sales | 0.00 |
| Price/FCF | -5.57 |
| Price/Op Cash Flow | -5.65 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0343 |
| Debt/Equity | 0.0373 |
| Debt/Capital | 0.0360 |
| Long-Term Debt/Capital | 0.0251 |
| Financial Leverage | 1.09 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.703 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 101.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -33.67 |
| Interest Coverage | -20641.6000 |
| Short-Term Operating Cash Flow Coverage | -25.19 |
| Operating Cash Flow Coverage | -7.80 |
| Capital Expenditure Coverage | -65.23 |
| Dividend + Capital Expenditure Coverage | -65.23 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -4.268 |
| Debt/Share | 0.4675 |
| Cash/Share | 12.71 |
| Book Value/Share | 12.51 |
| Tangible BV/Share | 12.51 |
| Equity/Share | 12.51 |
| Operating Cash Flow/Share | -3.646 |
| Capital Expenditure/Share | 0.056 |
| FCF/Share | -3.702 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.875 |
| Price/Fair Value | 1.65 |
| Debt/Market Cap | 0.0227 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -3.31 |